A detailed history of Intech Investment Management LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 14,897 shares of PYXS stock, worth $23,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,897
Holding current value
$23,388
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$2.83 - $3.94 $42,158 - $58,694
14,897 New
14,897 $54,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $55.1M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.